Compound information
- Natural Products
- ZC3408623
- Molecular Formula
- C26H27F4N7O2
- Molecular Weight
- 545.216235984 g/mol
- Structure
-
- IUPAC Name
- N-[3-[[2-[4-[[1-(2-fluoroethyl)azetidin-3-yl]amino]-2-methoxy-anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide
- InChI
- InChI=1S/C26H27F4N7O2/c1-3-23(38)33-16-5-4-6-17(11-16)34-24-20(26(28,29)30)13-31-25(36-24)35-21-8-7-18(12-22(21)39-2)32-19-14-37(15-19)10-9-27/h3-8,11-13,19,32H,1,9-10,14-15H2,2H3,(H,33,38)(H2,31,34,35,36)
- InChI Key
- BFSRTTWIPACGMI-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC4CN(CCF)C4)cc3OC)ncc2C(F)(F)F)c1
- Source
- ZINC000102241092
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 39 | Ring Count | 4 |
Heteroatom Count | 13 | Rotatable Bond Count | 11 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 103.44 Å2 | LogP | 4.512 |
LogS | -4.286 | LogD | 3.769 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.369 | Pgp substrate | 0.991 |
HIA | 0.921 | F20 % | 0.978 |
F30 % | 0.087 | Caco-2 | -5.109 |
MDCK | -4.757 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.005 | PPB | 97.062 |
VD | 1.606 | Fu | 2.046 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.967 | CYP1A2 substrate | 0.576 |
CYP2A6 substrate | 0.289 | CYP2B6 substrate | 0.529 |
CYP2C19 inhibitor | 0.842 | CYP2C19 substrate | 0.925 |
CYP2C8 substrate | 0.868 | CYP2C9 inhibitor | 0.381 |
CYP2C9 substrate | 0.115 | CYP2D6 inhibitor | 0.779 |
CYP2D6 substrate | 0.934 | CYP2E1 substrate | 0.106 |
CYP3A4 inhibitor | 0.906 | CYP3A4 substrate | 0.95 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.073 | CL | 7.53 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.968 | Hepatotoxicity | 0.995 |
Mutagenicity | 0.66 | Rat Oral Acute Toxicity | 0.458 |
FDAMDD | 0.909 | Skin Sensitization | 0.34 |
Carcinogenicity | 0.013 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.989 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.131 | IGC50 | 3.604 |
LC50FM | 0.532 | LC50DM | 5.23 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.52 | NR-AR-LBD | 0.438 |
NR-AhR | 0.814 | NR-Aromatase | 0.262 |
NR-ER | 0.524 | NR-ER-LBD | 0.565 |
NR-PPAR-gamma | 0.88 | SR-ARE | 0.955 |
SR-ATAD5 | 0.762 | SR-HSE | 0.869 |
SR-MMP | 0.976 | SR-p53 | 0.935 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.